How Collagen Supplements May Help with Obesity, Diabetes, and Heart Disease Risk | Research

The takeaway

Collagen supplementation shows multi-target benefits in metabolic syndrome — from increasing satiety and GLP-1 secretion to improving insulin sensitivity and lowering blood pressure.

Multi-pathway
Collagen peptides affect GLP-1, DPP-IV, ACE, PPAR-α, and AMPK pathways relevant to metabolic syndrome

What the researchers found

Collagen peptides show multi-pathway benefits for metabolic syndrome including GLP-1 stimulation, DPP-IV inhibition, ACE inhibition, and AMPK activation.

Why it matters

A widely available supplement showing mechanistic benefits across multiple metabolic syndrome components could complement pharmaceutical approaches.

The numbers in context

No specific clinical trial results; reviews mechanistic data from preclinical and limited human studies.

How the study worked

Narrative review integrating human clinical evidence with preclinical mechanistic studies.

Who was studied

Adults with or at risk of metabolic syndrome

What this study cannot tell us

Narrative review — human evidence is limited and mechanistic data is largely preclinical. Supplement quality varies widely.

How to read the evidence

Narrative review — plausible mechanisms supported by preclinical data but limited human trial evidence.

When this study was published

Published in 2025, synthesizing the emerging evidence for collagen in metabolic health.

The bigger picture

If confirmed in large trials, collagen supplementation could become an accessible, low-risk adjunct to metabolic syndrome management.

Questions still open

What dose and type of collagen is most effective for metabolic benefits?
Can collagen supplements meaningfully complement GLP-1 drug therapy?

Common questions

Can collagen supplements help with diabetes?

Early evidence suggests collagen peptides may improve insulin sensitivity and prolong GLP-1 activity, but more human studies are needed.

How does collagen lower blood pressure?

Collagen peptides can inhibit ACE — the same enzyme targeted by common blood pressure medications — though the effect is weaker than pharmaceutical drugs.

Read the original research

Collagen supplementation in metabolic syndrome: a narrative review unraveling the biological mechanisms and effects.

Nutrition research reviews, 39, e10

View on PubMed ↗Publisher’s paper ↗

Citation

Pueyo-Arias, Marián; López-Yoldi, Miguel; Navas-Carretero, Santiago; González-Navarro, Carlos J; Zulet, María de Los Ángeles; Milagro, Fermin I. (2025). Collagen supplementation in metabolic syndrome: a narrative review unraveling the biological mechanisms and effects.. Nutrition research reviews, 39, e10. https://doi.org/10.1017/S0954422425100309